Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded, Placebo-controlled Trial of IV Ondansetron to Prevent Pruritus in Children Who Receive Intrathecal Morphine

NCT03262038 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03262038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03262038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded, Placebo-controlled Trial of IV Ondansetron to Prevent Pruritus in Children Who Receive Intrathecal Morphine
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Terminated
Start date
December 7, 2017
Completion date
August 20, 2019
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea/vomiting, pruritus